The drug at the center of the question is propofol, a short-acting agent that has become the workhorse of general anesthesia for oocyte retrieval worldwide. Propofol acts rapidly on the central nervous system by modulating GABA receptors, producing sedation within seconds and clearing quickly once the infusion stops, which makes it ideal for procedures lasting under an hour. But propofol is also lipophilic and biologically active, and laboratory studies have suggested it can cross the follicular barrier and appear in follicular fluid. Animal and in vitro experiments have raised the theoretical possibility that anesthetic exposure around the time of fertilization could perturb calcium signaling, spindle dynamics, or mitochondrial activity in the oocyte, processes that are critical in the hours and days that follow. Whether these laboratory signals translate into any meaningful effect on real human embryos has remained stubbornly unclear.

The research team, led by Xingwu Wu and colleagues, tackled the problem with a tool that only recently became standard in advanced embryology laboratories: time-lapse imaging, or TLI. Conventional embryo assessment relies on brief, discrete snapshots, with embryologists lifting embryos from their incubators once a day to grade them under a microscope. That approach misses nearly everything that matters, because the most informative events of early development, including pronuclear appearance, syngamy, and each successive cell division, unfold in the dark between observations. Time-lapse incubators solve this by photographing each embryo every few minutes without disturbing it, generating a continuous film of development. The resulting timeline of events, known as morphokinetics, gives researchers an exquisitely sensitive readout of embryonic health, and it is precisely the kind of instrument needed to detect subtle delays or disruptions that an anesthetic agent might cause.

Between April and July 2023, the team enrolled 210 infertile women undergoing IVF or intracytoplasmic sperm injection at their center. Of these, 101 received propofol-based general anesthesia during oocyte retrieval, while 109 underwent the procedure without general anesthesia and served as the control group. Because the study was retrospective, the investigators took care to verify that the two groups were comparable before drawing any conclusions, and indeed baseline characteristics and ovarian stimulation outcomes were similar across the board. The number of oocytes retrieved did not differ significantly, nor did the hormonal profiles, laboratory metrics, or stimulation parameters that might otherwise confound a comparison of embryo quality. This methodological grounding matters enormously in anesthesia research, where differences in patient populations can easily masquerade as drug effects.

The primary outcomes were the morphokinetic parameters captured by the time-lapse system, and here the study delivered its most important findings. The researchers tracked the timing of pronuclear appearance, the moment when the two parental genetic packages first become visible as distinct structures within the fertilized egg, as well as the timings of cleavage to the two-, three-, four-, five-, and eight-cell stages, denoted t2 through t8. They also measured the onset of compaction, the start of blastulation, the time to full blastocyst formation, and the timing of blastocyst expansion. Across every one of these landmarks, the embryos of women who had received propofol were statistically indistinguishable from those of women who had not. The developmental clocks of the two groups ticked in unison, hour by hour, from fertilization through the blastocyst stage.

Secondary outcomes told the same story at the level of the laboratory and the clinic. The rate of normal fertilization, defined by the appearance of two pronuclei, was comparable between groups, as was the cleavage rate, the proportion of day-three embryos judged to be of good quality, and the rate at which embryos progressed to blastocysts. When fresh embryos were transferred, clinical pregnancy rates, miscarriage rates, and live birth rates were all similar between the anesthesia and control groups. In other words, the chain of events that begins with an anesthetized egg retrieval and ends with a take-home baby showed no detectable weak links attributable to propofol. For a field in which patients scrutinize every decision for possible harm to their chances, this consistency across endpoints carries real weight.

The technical strength of the study lies in its use of continuous morphokinetic monitoring rather than static morphology grading alone. Static grading can only describe what an embryo looks like at a given moment, whereas morphokinetics reveals how it got there, including subtle timing anomalies such as direct cleavage from one cell to three, prolonged pronuclear fading, or abnormal synchrony between cell divisions, all of which have been associated with poorer implantation potential in prior literature. Had propofol exposure imposed even a modest developmental delay or increased the frequency of atypical cleavage patterns, a time-lapse platform of this kind would be well positioned to detect it. The absence of any such signal, across a battery of timed landmarks, therefore represents a genuinely rigorous form of negative evidence rather than a simple failure to observe gross abnormalities.

As with any retrospective cohort study, the findings come with caveats that the authors and independent readers alike should keep in view. Allocation to anesthesia was not randomized, so residual confounding by indication, meaning systematic differences between patients who chose or were assigned general anesthesia and those who did not, cannot be entirely excluded, even with comparable baseline characteristics. The single-center design, while ensuring uniform laboratory protocols and embryology practices, means the results reflect one institution’s patient population and clinical routines. The sample size of 210 participants, though adequate for detecting moderate differences in morphokinetic timing, may not have been powered to exclude very small effects on rare outcomes such as miscarriage. The authors also note that the study was approved by their institutional ethics committee with written informed consent from all participants, and it was funded by the Natural Science Foundation of Jiangxi Province.

Even with those limitations, the study lands at a consequential moment. Propofol remains the default anesthetic for oocyte retrieval in most fertility centers because it offers rapid onset, swift recovery, and reliable patient comfort during an uncomfortable transvaginal needle procedure, and alternatives such as conscious sedation or paracervical blocks each carry their own trade-offs in efficacy and tolerability. Persistent uncertainty about embryonic effects has left some patients and clinicians to weigh comfort against a feared, but unquantified, reproductive risk. By combining a clinically relevant exposure, a sensitive continuous imaging platform, and a full chain of outcomes from fertilization through live birth, the Nanchang team has provided the kind of reassuring, mechanistically informed data that the field has needed. The message for patients heading into an egg retrieval is straightforward: choosing general anesthesia with propofol to stay comfortable during the procedure does not appear to cost their embryos anything measurable, either in the incubator or in the clinic.

Subject of Research: Effects of propofol general anesthesia during oocyte retrieval on embryo morphokinetics and IVF clinical outcomes

Article Title: Effects of general anesthesia with propofol during oocyte retrieval on embryo morphokinetics and clinical outcomes: a retrospective cohort study

Article References: Wu, X., Zhong, Y., Xia, L., Huang, J., Chen, J., Zhang, Z., Liu, P., Tian, L., Tan, J., Chen, H., Xin, C., Huang, Z., & Zhao, Y. (2026). Effects of general anesthesia with propofol during oocyte retrieval on embryo morphokinetics and clinical outcomes: a retrospective cohort study. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02289-2

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02289-2

Keywords: propofol, general anesthesia, oocyte retrieval, IVF, ICSI, embryo morphokinetics, time-lapse imaging, blastocyst, clinical pregnancy, live birth, fertility treatment, retrospective cohort study